<!DOCTYPE article PUBLIC "-//NLM//DTD JATS (Z39.96) Journal Archiving and Interchange DTD v1.0 20120330//EN" "JATS-archivearticle1.dtd">
<article xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" article-type="research-article"><?properties open_access?><front><journal-meta><journal-id journal-id-type="nlm-ta">J Appl Oral Sci</journal-id><journal-id journal-id-type="iso-abbrev">J Appl Oral Sci</journal-id><journal-id journal-id-type="publisher-id">J. Appl. Oral. Sci.</journal-id><journal-title-group><journal-title>Journal of Applied Oral Science</journal-title></journal-title-group><issn pub-type="ppub">1678-7757</issn><issn pub-type="epub">1678-7765</issn><publisher><publisher-name>Faculdade de Odontologia de Bauru da Universidade de S&#x000e3;o
Paulo</publisher-name></publisher></journal-meta><article-meta><article-id pub-id-type="pmid">24676580</article-id><article-id pub-id-type="pmc">3956401</article-id><article-id pub-id-type="doi">10.1590/1678-775720130540</article-id><article-categories><subj-group subj-group-type="heading"><subject>Original Articles</subject></subj-group></article-categories><title-group><article-title>Serum leveis of inflammatory markers in type 2 diabetes patients with
chronic periodontitis</article-title></title-group><contrib-group><contrib contrib-type="author"><name><surname>LONGO</surname><given-names>Priscila Larcher</given-names></name><xref ref-type="aff" rid="aff01">1</xref><xref ref-type="corresp" rid="c01"/></contrib><contrib contrib-type="author"><name><surname>ARTESE</surname><given-names>Hilana Paula Carillo</given-names></name><xref ref-type="aff" rid="aff02">2</xref></contrib><contrib contrib-type="author"><name><surname>RABELO</surname><given-names>Marianade Sousa</given-names></name><xref ref-type="aff" rid="aff02">2</xref></contrib><contrib contrib-type="author"><name><surname>KAWAMOTO</surname><given-names>Dione</given-names></name><xref ref-type="aff" rid="aff01">1</xref></contrib><contrib contrib-type="author"><name><surname>FOZ</surname><given-names>Adriana Moura</given-names></name><xref ref-type="aff" rid="aff02">2</xref></contrib><contrib contrib-type="author"><name><surname>ROMITO</surname><given-names>Giuseppe Alexandre</given-names></name><xref ref-type="aff" rid="aff02">2</xref></contrib><contrib contrib-type="author"><name><surname>DIB</surname><given-names>S&#x000e9;rgio Atala</given-names></name><xref ref-type="aff" rid="aff03">3</xref></contrib><contrib contrib-type="author"><name><surname>MAYER</surname><given-names>Marcia Pinto Alves</given-names></name><xref ref-type="aff" rid="aff01">1</xref></contrib></contrib-group><aff id="aff01"><label>1</label> Department of Microbiology, Institute of Biomedical Sciences,
University of S&#x000e3;o Paulo, S&#x000e3;o Paulo, SP, Brazil. </aff><aff id="aff02"><label>2</label> Division of Periodontics, Department of Stomatology, School of
Dentistry, University of S&#x000e3;o Paulo, S&#x000e3;o Paulo, SP, Brazil. </aff><aff id="aff03"><label>3</label> Department of Endocrinology, School of Medicine, Federal University of
S&#x000e3;o Paulo, S&#x000e3;o Paulo, SP, Brazil. </aff><author-notes><corresp id="c01"><bold>Corresponding address:</bold> Priscila Larcher Longo - Departamento de
Microbiologia, Instituto de Ci&#x000ea;ncias Biom&#x000e9;dicas - Universidade de S&#x000e3;o Paulo - Av.
Lineu Prestes, 1374 - S&#x000e3;o Paulo - SP - 05508-900 - Brazil - Phone: 55-11-3091-7348 -
e-mail: <email>pllongo@usp.br</email></corresp></author-notes><pub-date pub-type="ppub"><season>Mar-Apr</season><year>2014</year></pub-date><volume>22</volume><issue>2</issue><fpage>103</fpage><lpage>108</lpage><history><date date-type="received"><day>28</day><month>9</month><year>2013</year></date><date date-type="rev-recd"><day>05</day><month>12</month><year>2013</year></date><date date-type="accepted"><day>12</day><month>12</month><year>2013</year></date></history><permissions><license license-type="open-access" xlink:href="http://creativecommons.org/licenses/by-nc/3.0/"><license-p>This is an Open Access article distributed under the terms of the Creative
Commons Attribution Non-Commercial License which permits unrestricted
non-commercial use, distribution, and reproduction in any medium, provided the
original work is properly cited. </license-p></license></permissions><abstract><p>Diabetes has been associated with periodontitis, but the mechanisms through which
periodontal diseases affect the metabolic control remain unclear.</p><sec><title>Objective</title><p> This study aimed to evaluate serum leveis of inflammatory markers, IL-8, IL-6 and
monocyte chemoattractant protein 1 (MCP-1), in type 2 diabetic patients in the
presence of chronic periodontitis. </p></sec><sec><title>Material and Methods</title><p> Forty two individuals were enrolled in this study and assigned to one of five
groups: diabetes mellitus with inadequate glycemic control and periodontitis
(DMI+P, n = 10), diabetes mellitus with adequate glycemic control and
periodontitis (DMA+P, n = 10), diabetes mellitus without periodontitis (DM, n =
10), periodontitis without diabetes (P, n=6), and neither diabetes nor
periodontitis (H, n = 6). Periodontal clinical examination included visible plaque
index (PL), gingival bleeding index (GB), probing depth (PD), attachment level
(AL) and bleeding on probing (BP). Glycemic control was evaluated by serum
concentration of glycated hemoglobin (HbAlc). Inflammatory serum markers IL-8,
IL-6 and (MCP-1) were measured by ELISA.</p></sec><sec><title>Results</title><p>DMI+P and DMA+P groups presented higher PD (p=0.025) and AL (p=0.003) values when
compared to the P group. There were no significant differences among groups for
IL-6, IL-8 and MCP-1 serum levels.</p></sec><sec><title>Conclusions</title><p> Although periodontitis was more severe in diabetic patients, the serum levels of
the investigated inflammatory markers did not differ among the groups.</p></sec></abstract><kwd-group><kwd>Diabetes mellitus</kwd><kwd>Periodontitis</kwd><kwd>Cytokines</kwd><kwd>Inflammation</kwd></kwd-group><funding-group><award-group><funding-source>S&#x000e3;o Paulo Research Foundation</funding-source><award-id>2011/18618-5</award-id><award-id>10057-4</award-id><award-id>06982-4</award-id></award-group></funding-group></article-meta></front><body><sec><title>INTRODUCTION</title><p>Type 2 diabetes mellitus (T2DM) is the most common endocrine disorder and its incidence
is increasing worldwide. This condition is a serious public health concern due to the
need for lifelong care, premature death and the fact that it remains incurable<sup><xref rid="r22" ref-type="bibr">22</xref></sup>. It is characterized by a progressive
deficient secretion and action of insulin. Insulin resistance, whereby target tissues do
not respond to this hormone, is a characteristic of the disease's first phase, when
there is often a corresponding hyperinsulinemia<sup><xref rid="r01" ref-type="bibr">1</xref></sup>. This resistance comes together with inflammatory processes in the
development of diabetes chronic complications<sup><xref rid="r32" ref-type="bibr">32</xref></sup>. Among these complications, periodontal diseases (PD) are very
common and immune modulating factors are necessary for pathogen clearance, but also
contribute to host tissues damage, as those seen in PD.</p><p>Clues to the involvement of inflammation in diabetes date back to more than a century
ago. Proinflammatory molecules as tumor necroses factor (TNF)-&#x003b1;, leptin, interleukin
(IL)-6, resistin, monocyte chemoattractant protein-1 (MCP-1) and visfatin, among others,
are expressed at high levels in activated macrophages and/or other cells.
Proinflammatory cytokines such as TNF-&#x003b1; and IL-1&#x003b2; activate JNK and IKK&#x003b2;/NF-&#x003ba;B through
classical receptor-mediated mechanisms which are also activated by pattern recognition
receptors, bound to substances as lipopolissacharide (LPS) from gram negative bacteria.
These include the Toll Like Receptors (TLRs) and the receptor for advanced glycation end
products (RAGE). Prolonged hyperglycemia and the accompanying production of excess
amounts of advanced glycation end products (AGEs) can activate NF-&#x003ba;B. JNK promotes
insulin resistance through the phosphorylation of serine residues in insulin receptor
signaling (IRS)-1 that negatively regulates normal signaling through the insulin
receptor/IRS-1 axis. NF-&#x003ba;B induces insulin resistance by promoting the expression of
numerous target genes as those for TNF-&#x003b1;, IL-6, IL-8, MCP-1, MIP-1&#x003b1;, MIP-2, resistin,
ICAM-1, VCAM-1<sup><xref rid="r29" ref-type="bibr">29</xref></sup>.</p><p>The inflammation associated with PD, characterized by elevated pro-inflammatory
cytokines, innate immune receptor expression, and cellular infiltrate is exacerbated in
patients with T2DM where TLR-4 and RAGEs play a significant role and contribute to
induce responses by oral epithelial cells<sup><xref rid="r02" ref-type="bibr">2</xref></sup>.</p><p>The local production of cytokines in response to periodontal bacteria and their products
results in higher serum concentrations of pro-inflammatory biomarkers<sup><xref rid="r13" ref-type="bibr">13</xref></sup> and a poor glycemic control in T2DM
patients is associated with a loss of mucosal barrier integrity and accumulation of
innate immune receptor ligands resulting in an exacerbation of ongoing
inflammation<sup><xref rid="r02" ref-type="bibr">2</xref></sup>.</p><p>Thus, the adverse effect of periodontitis in T2DM may be explained by an increase in
systemic inflammation, which contributes to insulin resistance<sup><xref rid="r19" ref-type="bibr">19</xref></sup>.</p><p>The interrelation between more severe PD and DM is established<sup><xref rid="r08" ref-type="bibr">8</xref>,<xref rid="r32" ref-type="bibr">32</xref></sup> and there are
evidences on the importance of cytokine analysis in T2DM evolution<sup><xref rid="r29" ref-type="bibr">29</xref></sup> and therapy blockade<sup><xref rid="r21" ref-type="bibr">21</xref></sup>.</p><p>As chronic or recurring inflammation contributes to an aberrant continuation of acute
phase response and may also lead to further diabetes complications, such as micro and
macroangiopathy and impaired healing<sup><xref rid="r14" ref-type="bibr">14</xref>,<xref rid="r28" ref-type="bibr">28</xref></sup>, it is suggested that periodontal
disease with increased inflammatory response at local and systemic levels<sup><xref rid="r30" ref-type="bibr">30</xref></sup> may collaborate to insulin resistance
present on T2DM pathogenesis. However, scientific evidence on the effects of chronic
periodontitis on diabetes mellitus remains inadequate and inconclusive<sup><xref rid="r09" ref-type="bibr">9</xref></sup>. Furthermore, whether periodontal therapy
may help to control serum levels of inflammatory cytokines still remains
controversial<sup><xref rid="r05" ref-type="bibr">5</xref></sup>. While some
studies showed an effective improvement in periodontal parameters, circulating
inflammatory markers and glycemic control after periodontal treatment in patients with
T2DM<sup><xref rid="r09" ref-type="bibr">9</xref>,<xref rid="r17" ref-type="bibr">17</xref>,<xref rid="r32" ref-type="bibr">32</xref></sup>, others have shown that
these responses were inconsistent across individuals and not sustainable over
time<sup><xref rid="r03" ref-type="bibr">3</xref>,<xref rid="r05" ref-type="bibr">5</xref>,<xref rid="r19" ref-type="bibr">19</xref></sup>.</p><p>The elevated levels of systemic inflammatory mediators, such as IL-6, in obesity or
metabolic syndrome enhance the host response to periodontal pathogens, hence increasing
the chance of periodontal destruction. IL-6 is a multifunctional cytokine produced by a
variety of cells including macrophages, neutrophils, and endothelial cells. The double
edge effects (i.e., pro- and anti-inflammatory) of this molecule entail complexity in
investigating its role and, until now, no evidence from animal or human studies supports
the hypothetical model in which metabolic syndrome-induced IL-6 increases the risk of
destructive periodontal disease<sup><xref rid="r18" ref-type="bibr">18</xref></sup>.</p><p>Interleukin 8 (IL-8) is a chemokine important for recruiting neutrophils during healing
and its levels were shown to be tightly linked to increased susceptibility to
periodontitis<sup><xref rid="r12" ref-type="bibr">12</xref></sup>.</p><p>Monocyte chemoattractant protein 1 (MCP-1) is also thought to play an important role in
inflammatory processes. It has been implicated as a key factor in recruitment and
activation of peripheral blood leukocytes in atherosclerotic lesions and adipose tissue.
Elevated levels of circulating MCP-1 have been found in patients with T2DM, and
experimental data have shown that this protein increases macrophage infiltration,
inflammation and insulin resistance in transgenic mice<sup><xref rid="r26" ref-type="bibr">26</xref></sup>.</p><p>Some studies<sup><xref rid="r03" ref-type="bibr">3</xref>,<xref rid="r06" ref-type="bibr">6</xref>,<xref rid="r09" ref-type="bibr"> 9</xref>,<xref rid="r17" ref-type="bibr">17</xref>,<xref rid="r24" ref-type="bibr">24</xref></sup> have evaluated
markers such as interleukin-6 (IL-6), tumor necrosis factor-a (TNF-&#x003b1;), C-reactive
protein (CRP), and IL-1&#x003b2; and related them to insulin resistance<sup><xref rid="r24" ref-type="bibr">24</xref></sup> and glycemic control<sup><xref rid="r03" ref-type="bibr">3</xref></sup>; however, their results are still
conflicting.</p><p>Based on the evidences that IL-6, IL-8 and MCP-1 are important key markers of immune
response, which have been considered as critical mediators of initiation, progression
and/or suppression of chronic periodontitis, and that no previous study had analyzed
this combination of mediators in groups with and without diabetes and periodontal
disease, this study aimed to evaluate serum levels of inflammatory markers, IL-8, IL-6
and MCP-1, in type 2 diabetic patients in the presence of chronic periodontitis.</p></sec><sec sec-type="methods"><title>PATIENTS AND METHODS</title><p>This study was conducted between January 2012 and March 2013 in full accordance with the
Helsinki Declaration of 1975, as revised in 2000. The study protocol and the informed
consent form were reviewed and approved by the Biomedical Sciences Institute Ethics
Committee (#011/CEP) from the University of S&#x000e3;o Paulo (S&#x000e3;o Paulo, Brazil). T2DM
individuals were recruited from the Diabetes Center at the Federal University of S&#x000e3;o
Paulo. Non-diabetic patients were recruited from the School of Dentistry, University of
S&#x000e3;o Paulo. Detailed medical and dental history was obtained from all patients. All
volunteers received full mouth periodontal clinical examination performed at six
sites<italic> per</italic> tooth (excluding third molars) from a calibrated examiner
(HPCA). Intraexaminer reliability for detecting PDs within 1 mm was &#x0003e;90%. The
presence of supragingival biofilm was recorded as plaque index (PL), marginal gingival
bleeding was recorded as gingival bleeding (GB); bleeding on probing (BP), probing depth
(PD) and attachment level (AL) were also evaluated. The probe used was North Caroline
(UNC-15, Hu-Friedy<sup>&#x000ae;</sup>, Chicago, IL, USA). PL, GB and BP were recorded as absent
(0) or present (1). Inclusion criteria were: age &#x02265;35 years, confirmed diagnosis of type
2 diabetes over 3 years (for individuals with T2DM), generalized moderate to severe
chronic periodontitis (American Academy of Periodontology, 1998) (&#x02265;30% of sites with PD
&#x0003e;4 mm and bleeding on probing) and &#x02265;15 remaining teeth. Pregnant women, smokers,
patients with Body Mass Index (BMI) &#x0003e;40 kg/m<sup>2</sup> or who received periodontal
therapy, antibiotic or antiseptic therapy 6 months prior to the study were excluded.
Blood samples were obtained and glycated hemoglobin (HbA1c) levels were determined for
all individuals at the clinical laboratory of the University of S&#x000e3;o Paulo Hospital.
Approximately 5 ml of blood were collected by venipuncture in untreated tubes (BD
Vacutainer Rapid Serum Tube, Becton Dickinson Co., S&#x000e3;o Paulo, SP, Brazil). Serum was
obtained by centrifugation at 2,500<italic> g</italic> for 2 minutes, aliquoted and
stored at -80&#x000b0;C until further analysis. Quantitative measurement of IL-6, IL-8 and MCP-1
was assayed by enzyme-linked immunosorbent assay (Human Standard ELISA Development Kit,
PeproTech Inc., Rocky Hill, CT, USA) and read out using a Micro Plate reader (Model 680,
Bio-Rad Laboratories Inc., Hercules, CA, USA). Serum from each patient was tested in
triplicate, and a calibration curve was added to each plate.</p><p>Forty-two individuals were enrolled in this study. Patients with T2DM and periodontitis
were divided in two groups, as adequate glycemic control when HbA1c &#x0003c;8.0% (DMA+P, n =
10) and inadequate glycemic control when HbA1c &#x02265;8.0% (DMI + P, n=10). The other 3 groups
were composed of T2DM individuals without periodontitis (DM, n = 10), non-diabetic with
periodontitis (P, n=6) and non-diabetic without periodontitis (H, n=6).</p><p>Periodontal clinical data were analyzed using appropriate statistical software (SPSS
version 17.0 for Windows, SPSS Inc., Chicago, IL, USA) considering the individual as a
study unit. The Kolmogorov-Smirnov test was used to test the variables normality
distribution. Data were analyzed by non-parametric statistical methods since data were
not normally distributed. Comparisons between groups were determined using
Kruskal-Wallis test and Tukey test. Tests were based on median values with variability
measures (25% and 75% quartiles). Results were considered statistically significant at
p&#x0003c;0.05. For GB, PL and BOP data, percentages of positive sites were obtained<italic>
per</italic> patient and, thereafter, median values were calculated for the groups.
For PD and AL, measured by millimeters, percent frequency was first obtained per patient
and, thereafter, as a median value for the group.</p><p>Data from ELISA were analyzed by Kruskal-Wallis and Dunn's Multiple Comparison Test
(Prism 5.0 Project, Graph Pad Software Inc., La Jolla, CA, USA). Values were obtained
per patient and a median value was calculated for each group.</p></sec><sec sec-type="results"><title>RESULTS</title><p>A total of 546 patients were assessed for eligibility, and only 42 fulfilled the
inclusion criteria (<xref ref-type="fig" rid="f01">Figure 1</xref>).</p><fig id="f01" orientation="portrait" position="float"><label>Figure 1</label><caption><p>Flow diagram of patients included in the study</p></caption><graphic xlink:href="jaos-22-02-0103-g01"/></fig><p>Demographic and HbA1c data from each group are described in <xref ref-type="table" rid="t01">Table 1</xref>.</p><table-wrap id="t01" orientation="portrait" position="float"><label>Table 1</label><caption><p>Demographic characteristics and glycated level (mean&#x000b1;standard deviation) for
participants in each group</p></caption><table frame="hsides" rules="groups"><thead><tr style="background-color:#dcddde"><th align="center" rowspan="1" colspan="1">
<bold>GROUPS</bold>
</th><th align="center" rowspan="1" colspan="1">
<bold>male</bold>
</th><th align="center" rowspan="1" colspan="1">
<bold>age</bold>
</th><th align="center" rowspan="1" colspan="1">
<bold>BMI</bold>
</th><th align="center" rowspan="1" colspan="1">
<bold>HbA1c</bold>
</th></tr></thead><tbody><tr><td align="center" rowspan="1" colspan="1"> H (n=6)</td><td align="center" rowspan="1" colspan="1"> 2</td><td align="center" rowspan="1" colspan="1"> 50.0&#x000b1;4.38</td><td align="center" rowspan="1" colspan="1"> 26.19&#x000b1;3.61</td><td align="center" rowspan="1" colspan="1"> 5.18&#x000b1;0.60</td></tr><tr style="background-color:#dcddde"><td align="center" rowspan="1" colspan="1"> P (n=6)</td><td align="center" rowspan="1" colspan="1"> 5</td><td align="center" rowspan="1" colspan="1"> 47.0&#x000b1;5.25</td><td align="center" rowspan="1" colspan="1"> 26.18&#x000b1;3.28</td><td align="center" rowspan="1" colspan="1"> 5.43&#x000b1;0.54</td></tr><tr><td align="center" rowspan="1" colspan="1"> DM (n=10)</td><td align="center" rowspan="1" colspan="1"> 6</td><td align="center" rowspan="1" colspan="1"> 57.2&#x000b1;8.80</td><td align="center" rowspan="1" colspan="1"> 26.18&#x000b1;2.37</td><td align="center" rowspan="1" colspan="1"> 7.33&#x000b1;0.78</td></tr><tr style="background-color:#dcddde"><td align="center" rowspan="1" colspan="1"> DMA+P (n=10)</td><td align="center" rowspan="1" colspan="1"> 6</td><td align="center" rowspan="1" colspan="1"> 60.6&#x000b1;10.67</td><td align="center" rowspan="1" colspan="1"> 27.34&#x000b1;4.38</td><td align="center" rowspan="1" colspan="1"> 6.83&#x000b1;0.78</td></tr><tr><td align="center" rowspan="1" colspan="1"> DMI+P (n=10)</td><td align="center" rowspan="1" colspan="1"> 4</td><td align="center" rowspan="1" colspan="1"> 52.7&#x000b1;5.54</td><td align="center" rowspan="1" colspan="1"> 28.92&#x000b1;6.36</td><td align="center" rowspan="1" colspan="1"> 10.86&#x000b1;2.21</td></tr></tbody></table><table-wrap-foot><fn><p>DM=type 2 diabetes mellitus; P=Periodontitis; BMI=body mass index. Groups: H
(DM-P-), P (DM-P+), DM (DM+P-), DMA+P (DM+with adequate glycemic control P+),
DMI+P (DM+with inadequate glycemic control P+)</p></fn></table-wrap-foot></table-wrap><p>
<xref ref-type="table" rid="t02">Table 2</xref> provides periodontal clinical parameters
for each group with periodontitis: DMI+P, DMA+P and P. There were significant
differences between diabetic (DMI+P and DMA+P) and non-diabetic (P) for PD (p=0.04) and
AL (p = 0.01) values indicating a more severe disease among the diabetic patients. The
other clinicai parameters did not differ significantly among groups. Intergroup clinical
parameters comparison for DMI + P and DMA+P showed no significant differences (data not
shown).</p><table-wrap id="t02" orientation="portrait" position="float"><label>Table 2</label><caption><p>Medians and quartiles (25-75%) of clinical parameters for the DMA+P, DMI+P and P
groups</p></caption><table frame="hsides" rules="groups"><thead><tr align="center" style="background-color:#dcddde"><th rowspan="1" colspan="1">
<bold>Clinical</bold>
</th><th rowspan="1" colspan="1">
<bold>DMA+P</bold>
</th><th rowspan="1" colspan="1">
<bold>DMI+P</bold>
</th><th rowspan="1" colspan="1">
<bold>P</bold>
</th><th rowspan="1" colspan="1">
<bold>p</bold>
</th></tr><tr align="center"><th rowspan="1" colspan="1">
<bold>Parameters</bold>
</th><th rowspan="1" colspan="1">
<bold>(n=10)</bold>
</th><th rowspan="1" colspan="1">
<bold>(n=10)</bold>
</th><th rowspan="1" colspan="1">
<bold>(n=6)</bold>
</th><th rowspan="1" colspan="1">
<bold>value</bold>
</th></tr></thead><tbody><tr align="center" style="background-color:#dcddde"><td rowspan="1" colspan="1"> GB (%)</td><td rowspan="1" colspan="1"> 71.35 (55.40-94.02)</td><td rowspan="1" colspan="1"> 59.02 (40.16-90.69)</td><td rowspan="1" colspan="1"> 58.85 (40.22-72.22)</td><td rowspan="1" colspan="1"> 0.34</td></tr><tr align="center"><td rowspan="1" colspan="1"> PL (%)</td><td rowspan="1" colspan="1"> 90.83 (68.00-97.90)</td><td rowspan="1" colspan="1"> 66.70 (52.52-97.00)</td><td rowspan="1" colspan="1"> 66.88 (52.40-81.62)</td><td rowspan="1" colspan="1"> 0.25</td></tr><tr align="center" style="background-color:#dcddde"><td rowspan="1" colspan="1"> BOP (%)</td><td rowspan="1" colspan="1"> 77.56 (68.24-94.54)</td><td rowspan="1" colspan="1"> 67.55 (40.52-93.68)</td><td rowspan="1" colspan="1"> 58.80(43.87-65.82)</td><td rowspan="1" colspan="1"> 0.88</td></tr><tr align="center"><td rowspan="1" colspan="1"> PD (mm)</td><td rowspan="1" colspan="1"> 3.60 (3.17-4.10)</td><td rowspan="1" colspan="1"> 3.40 (3.00-4.10)</td><td rowspan="1" colspan="1"> 3.00 (2.87-3.22)</td><td rowspan="1" colspan="1"> 0.04<xref ref-type="table-fn" rid="t02-fn01">*</xref>
</td></tr><tr align="center" style="background-color:#dcddde"><td rowspan="1" colspan="1"> AL (mm)</td><td rowspan="1" colspan="1"> 4.45 (3.82-5.05)</td><td rowspan="1" colspan="1"> 4.20 (3.70-4.90)</td><td rowspan="1" colspan="1"> 3.4 (3.25-3.65)</td><td rowspan="1" colspan="1"> 0.01<xref ref-type="table-fn" rid="t02-fn01">*</xref>
</td></tr></tbody></table><table-wrap-foot><fn id="t02-fn01"><label>*</label><p>Statistically significance difference between DMA+P;DMI+P and P
(Kruskall-Wallis Test and Tukey Test; &#x003b1;=5%). GB= gingival bleeding index;
PL=visible plaque index; BOP=bleeding on probing; PD=probing depth;
AL=attachment level</p></fn></table-wrap-foot></table-wrap><p>There were no differences between groups for IL-6 (p=0.6351), IL-8 (p=0.9460) and MCP-1
(p=0.2987) sera leveis (<xref ref-type="fig" rid="f02">Figure 2</xref>).</p><fig id="f02" orientation="portrait" position="float"><label>Figure 2</label><caption><p>IL-6 (A), IL-8 (B) and MCP-1 (C) serum levels in patients without periodontitis
and T2DM (H), patients with periodontitis and without T2DM (P), patients with T2DM
and without periodontitis (DM), patients with T2DM with adequate glycemic control
and periodontitis (DMA+P) and patients with T2DM with inadequate glycemic control
and periodontitis (DMI+P). MCP-1=monocyte chemoattractant protein-1;
IL-6=interleukin 6; IL-8=interleukin 8; T2DM=Type 2 diabetes mellitus.</p></caption><graphic xlink:href="jaos-22-02-0103-g02"/></fig></sec><sec sec-type="discussion"><title>DISCUSSION</title><p>The present study evaluated clinical and inflammatory parameters among groups with and
without T2DM and/or periodontitis.</p><p>T2DM patients presented significantly higher PD and AL values when compared to group P,
without diabetes and with periodontitis. This result is consistent with a number of
cross-sectional and longitudinal studies<sup><xref rid="r16" ref-type="bibr">16</xref>,<xref rid="r20" ref-type="bibr">20</xref>,<xref rid="r31" ref-type="bibr">31</xref></sup> which had shown that the increased severity of PD in
T2DM patients is due to an interorgan crosstalk under inflammatory conditions<sup><xref rid="r18" ref-type="bibr">18</xref></sup>.</p><p>The positive correlation between glycemic control and severity of periodontal disease
has been reported in the literature<sup><xref rid="r08" ref-type="bibr">8</xref>,<xref rid="r15" ref-type="bibr">15</xref>,<xref rid="r34" ref-type="bibr">34</xref></sup>. Thus, we had expected to find a significant relationship between
HbA1c levels (representing adequate - HbA1c &#x0003c;8.0% - and inadequate - HbA1c &#x02265;8.0% -
glycemic control) and periodontitis severity (in terms of increased PD and BOP).
However, the periodontal clinical parameters data did not differ according to the
diabetes control, corresponding to DMA+P and DMI+P groups, respectively. We can
speculate that, in order to observe correlation, we would need to consider a stricter
glycemic control of individuals with T2DM, that is, HbA1c between 6.5 and 7.0%, which
would hamper even more the group selection. Besides, HbA1c refers to glycemic control in
the last 2 or 3 months and we do not know how the chronic glycemic control in these
individuals was. We also have to point out that hyperglycemia is only one factor of the
multifactorial process of periodontal disease.</p><p>There were no differences among IL-6 serum levels in the 5 groups analyzed. The role of
locally produced IL-6 in the periodontitis pathogenesis has been demonstrated<sup><xref rid="r04" ref-type="bibr">4</xref>,<xref rid="r25" ref-type="bibr">25</xref></sup>, since high levels of this cytokine were detected in symptomatic large
lesions rather than in asymptomatic small lesions<sup><xref rid="r04" ref-type="bibr">4</xref></sup>. This cytokine is overexpressed in sites with PD mainly in
patients without diabetes and patients with well-controlled T2DM when compared with
patients with poorly controlled diabetes<sup><xref rid="r35" ref-type="bibr">35</xref></sup>. The effect of periodontal treatment on IL-6 levels showed
conflicting data, yielding a tendency toward a decrease<sup><xref rid="r07" ref-type="bibr">7</xref>,<xref rid="r32" ref-type="bibr">32</xref></sup> or increase in
serum levels in T2DM patients<sup><xref rid="r33" ref-type="bibr">33</xref></sup>.
Furthermore, a controversial study suggested an increase or no change in serum IL-6
levels in obesity and metabolic syndrome<sup><xref rid="r18" ref-type="bibr">18</xref></sup>. It should be noticed that T2DM individuals evaluated in the present
study were under treatment with insulin, which may have induced low levels of
inflammatory biomarkers such as IL-6<sup><xref rid="r06" ref-type="bibr">6</xref>,<xref rid="r23" ref-type="bibr">23</xref></sup>, counteracting the high levels induced
by periodontal inflammation.</p><p>In the present study, there were no significant differences in the sera levels of the
studied inflammatory markers, MCP-1 and IL-8, among the groups, although previous data
demonstrated that both were overexpressed in the gingival tissue with chronic
periodontitis<sup><xref rid="r35" ref-type="bibr">35</xref></sup>. A search in the
literature revealed no study in humans regarding T2DM and/ or periodontitis and MCP-1
serum or gingival fluid levels. In rats experimental models, MCP-1 gingival crevicular
fluid concentrations did not significantly differ between groups with diabetes and
periodontitis and its levels were higher than in control healthy group<sup><xref rid="r27" ref-type="bibr">27</xref></sup>.</p><p>High levels of IL-8 were shown in the gingival fluid of subjects with periodontal
disease. However, subjects with T2DM presented significantly lower levels of IL-8 in the
GCF when compared to healthy ones and there was no correlation between IL-8 gingival
levels and HbA1c level<sup><xref rid="r10" ref-type="bibr">10</xref>,<xref rid="r11" ref-type="bibr">11</xref></sup>. Furthermore, IL-8 levels in serum
tended to decrease after periodontal therapy in T2DM patients<sup><xref rid="r07" ref-type="bibr">7</xref></sup>.</p><p>Due to the use of restrictive inclusion and exclusion criteria, in an attempt to
minimize the occurrence of confounding factors, the small sample size is one limitation
of this study. However, it is interesting to consider that some studies evaluated only
specific dental sites through gingival crevicular fluid analysis, whereas the serum
analysis provides a more valuable analysis of the inflammatory markers in the subject.
To the best of our knowledge, there have been no studies evaluating these serum markers
under all different conditions analyzed in this study.</p><p>Nevertheless, this study confirms the higher severity of periodontal disease in
individuals with diabetes, highlighting the need for special oral healthcare for these
patients. This study pointed out the great variability of the serum inflammatory
biomarkers under all systemic and periodontal conditions studied. We can suggest that
follow-up studies with stricter glycemic control and larger samples should be conducted
in order to investigate the cumulative influence of periodontal conditions on serum
inflammatory biomarkers in individuals with T2DM.</p></sec><sec sec-type="conclusions"><title>CONCLUSION</title><p>Although periodontitis was more severe in patients with diabetes, the serum levels of
the investigated inflammatory markers were not different among the periodontitis
patients.</p></sec></body><back><ack><title>ACKNOWLEDGMENTS</title><p>We would like to thank Dr. Anna Carolina R. T. Horliana and Dr. Giovane H. Gomes for
their collaboration in clinical procedures. This study was supported by S&#x000e3;o Paulo
Research Foundation (FAPESP), S&#x000e3;o Paulo, Brazil, under protocol numbers 2011/18618-5;
10057-4; 06982-4.</p></ack><ref-list><title>REFERENCES</title><ref id="r01"><label>1</label><element-citation publication-type="journal"><person-group person-group-type="author"><collab>American Diabetes Association</collab></person-group><article-title>Standards of medical care in diabetes - 2011</article-title><source>Diabetes Care</source><year>2011</year><volume>34</volume><issue>Suppl 1</issue><fpage>S11</fpage><lpage>S61</lpage><pub-id pub-id-type="pmid">21193625</pub-id></element-citation></ref><ref id="r02"><label>2</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Amir</surname><given-names>J</given-names></name><name><surname>Waite</surname><given-names>M</given-names></name><name><surname>Tobler</surname><given-names>J</given-names></name><name><surname>Catalfamo</surname><given-names>DL</given-names></name><name><surname>Koutouzis</surname><given-names>T</given-names></name><name><surname>Katz</surname><given-names>J</given-names></name><etal>et al</etal></person-group><article-title>The role of hyperglycemia in mechanisms of exacerbated inflammatory
responses within the oral cavity</article-title><source>Cell Immunol</source><year>2011</year><volume>272</volume><issue>1</issue><fpage>45</fpage><lpage>52</lpage><pub-id pub-id-type="pmid">21996642</pub-id></element-citation></ref><ref id="r03"><label>3</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Auyeung</surname><given-names>L</given-names></name><name><surname>Wang</surname><given-names>PW</given-names></name><name><surname>Lin</surname><given-names>RT</given-names></name><name><surname>Hsieh</surname><given-names>CJ</given-names></name><name><surname>Lee</surname><given-names>PY</given-names></name><name><surname>Zhuang</surname><given-names>RY</given-names></name><etal>et al</etal></person-group><article-title>Evaluation of periodontal status and effectiveness of non-surgical
treatment in patients with type 2 diabetes mellitus in Taiwan for a 1-year
period</article-title><source>J Periodontol</source><year>2012</year><volume>83</volume><issue>5</issue><fpage>621</fpage><lpage>628</lpage><pub-id pub-id-type="pmid">21692625</pub-id></element-citation></ref><ref id="r04"><label>4</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Azuma</surname><given-names>MM</given-names></name><name><surname>Samuel</surname><given-names>RO</given-names></name><name><surname>Gomes-Filho</surname><given-names>JE</given-names></name><name><surname>Dezan-Junior</surname><given-names>E</given-names></name><name><surname>Cintra</surname><given-names>LT</given-names></name></person-group><article-title>The role of IL-6 on apical periodontitis: a systematic
review</article-title><source>Int Endod J</source><year>2013</year><pub-id pub-id-type="doi">10.1111/iej.12196</pub-id><comment>Epub ahead of print</comment></element-citation></ref><ref id="r05"><label>5</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Behle</surname><given-names>JH</given-names></name><name><surname>Sedaghatfar</surname><given-names>MH</given-names></name><name><surname>Demmer</surname><given-names>RT</given-names></name><name><surname>Wolf</surname><given-names>DL</given-names></name><name><surname>Celenti</surname><given-names>R</given-names></name><name><surname>Kebschull</surname><given-names>M</given-names></name><etal>et al</etal></person-group><article-title>Heterogeneity of systemic inflammatory responses to periodontal
therapy</article-title><source>J Clin Periodontol</source><year>2009</year><volume>36</volume><issue>4</issue><fpage>287</fpage><lpage>294</lpage><pub-id pub-id-type="pmid">19426174</pub-id></element-citation></ref><ref id="r06"><label>6</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Beisswenger</surname><given-names>PJ</given-names></name><name><surname>Brown</surname><given-names>WV</given-names></name><name><surname>Ceriello</surname><given-names>A</given-names></name><name><surname>Le</surname><given-names>NA</given-names></name><name><surname>Goldberg</surname><given-names>RB</given-names></name><name><surname>Cooke</surname><given-names>JP</given-names></name><etal>et al</etal></person-group><article-title>Meal induced increases in C-reactive protein, interleukin-6 and tumour
necrosis factor a are attenuated by prandial + basal insulin in patients with type
2 diabetes</article-title><source>Diabet Med</source><year>2011</year><volume>28</volume><issue>9</issue><fpage>1088</fpage><lpage>1095</lpage><pub-id pub-id-type="pmid">21517955</pub-id></element-citation></ref><ref id="r07"><label>7</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Correa</surname><given-names>FO</given-names></name><name><surname>Gon&#x000e7;alves</surname><given-names>D</given-names></name><name><surname>Figueredo</surname><given-names>CM</given-names></name><name><surname>Bastos</surname><given-names>AS</given-names></name><name><surname>Gustafsson</surname><given-names>A</given-names></name><name><surname>Orrico</surname><given-names>SR</given-names></name></person-group><article-title>Effect of periodontal treatment on metabolic control, systemic
inflammation and cytokines in patients with type 2 diabetes</article-title><source>J Clin Periodontol</source><year>2010</year><volume>37</volume><issue>1</issue><fpage>53</fpage><lpage>58</lpage><pub-id pub-id-type="pmid">19968741</pub-id></element-citation></ref><ref id="r08"><label>8</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Costa</surname><given-names>FO</given-names></name><name><surname>Miranda Cota</surname><given-names>LO</given-names></name><name><surname>Pereira Lages</surname><given-names>EJ</given-names></name><name><surname>Soares Dutra Oliveira</surname><given-names>AM</given-names></name><name><surname>Dutra Oliveira</surname><given-names>PA</given-names></name><name><surname>Cyrino</surname><given-names>RM</given-names></name><etal>et al</etal></person-group><article-title>Progression of periodontitis and tooth loss associated with glycemic
control in individuals undergoing periodontal maintenance therapy: a 5-year
follow-up study</article-title><source>J Periodontol</source><year>2013</year><volume>84</volume><issue>5</issue><fpage>595</fpage><lpage>605</lpage><pub-id pub-id-type="pmid">22769441</pub-id></element-citation></ref><ref id="r09"><label>9</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Chen</surname><given-names>L</given-names></name><name><surname>Luo</surname><given-names>G</given-names></name><name><surname>Xuan</surname><given-names>D</given-names></name><name><surname>Wei</surname><given-names>B</given-names></name><name><surname>Liu</surname><given-names>F</given-names></name><name><surname>Li</surname><given-names>J</given-names></name><etal>et al</etal></person-group><article-title>Effects of non-surgical periodontal treatment on clinical response,
serum inflammatory parameters, and metabolic control in patients with type 2
diabetes: a randomized study</article-title><source>J Periodontal</source><year>2012</year><volume>83</volume><issue>4</issue><fpage>435</fpage><lpage>443</lpage></element-citation></ref><ref id="r10"><label>10</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Duarte</surname><given-names>PM</given-names></name><name><surname>Oliveira</surname><given-names>MC</given-names></name><name><surname>Tambeli</surname><given-names>CH</given-names></name><name><surname>Parada</surname><given-names>CA</given-names></name><name><surname>Casati</surname><given-names>MZ</given-names></name><name><surname>Nociti</surname><given-names>FH</given-names><suffix>Jr</suffix></name></person-group><article-title>Overexpression of interleukin-1beta and interleukin-6 may play an
important role in periodontal breakdown in type 2 diabetic
patients</article-title><source>J Periodontal Res</source><year>2007</year><volume>42</volume><issue>4</issue><fpage>377</fpage><lpage>381</lpage><pub-id pub-id-type="pmid">17559636</pub-id></element-citation></ref><ref id="r11"><label>11</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Engebretson</surname><given-names>SP</given-names></name><name><surname>Vossughi</surname><given-names>F</given-names></name><name><surname>Hey-Hadavi</surname><given-names>J</given-names></name><name><surname>Emingil</surname><given-names>G</given-names></name><name><surname>Grbic</surname><given-names>JT</given-names></name></person-group><article-title>The influence of diabetes on gingival crevicular fluid
beta-glucuronidase and interleukin-8</article-title><source>J Clin Periodontol</source><year>2006</year><volume>33</volume><issue>11</issue><fpage>784</fpage><lpage>790</lpage><pub-id pub-id-type="pmid">16911568</pub-id></element-citation></ref><ref id="r12"><label>12</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Figueredo</surname><given-names>CM</given-names></name><name><surname>Gustafsson</surname><given-names>A</given-names></name></person-group><article-title>Increased amounts of laminin in GCF from untreated patients with
periodontitis</article-title><source>J Clin Periodontol</source><year>2000</year><volume>27</volume><issue>5</issue><fpage>313</fpage><lpage>318</lpage><pub-id pub-id-type="pmid">10847534</pub-id></element-citation></ref><ref id="r13"><label>13</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>G&#x000f3;rska</surname><given-names>R</given-names></name><name><surname>Gregorek</surname><given-names>H</given-names></name><name><surname>Kowalski</surname><given-names>J</given-names></name><name><surname>Laskus-Perendyk</surname><given-names>A</given-names></name><name><surname>Syczewska</surname><given-names>M</given-names></name><name><surname>Madalinski</surname><given-names>K</given-names></name></person-group><article-title>Relationship between clinical parameters and cytokine profiles in
inflamed gingival tissue and serum samples from patients with chronic
periodontitis</article-title><source>J Clin Periodontol</source><year>2003</year><volume>30</volume><issue>12</issue><fpage>1046</fpage><lpage>1052</lpage><pub-id pub-id-type="pmid">15002890</pub-id></element-citation></ref><ref id="r14"><label>14</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Graves</surname><given-names>DT</given-names></name><name><surname>Kayal</surname><given-names>RA</given-names></name></person-group><article-title>Diabetic complications and dysregulated innate
immunity</article-title><source>Front Biosci</source><year>2008</year><volume>13</volume><issue>1</issue><fpage>1227</fpage><lpage>1239</lpage><pub-id pub-id-type="pmid">17981625</pub-id></element-citation></ref><ref id="r15"><label>15</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Haseeb</surname><given-names>M</given-names></name><name><surname>Khawaja</surname><given-names>KI</given-names></name><name><surname>Ataullah</surname><given-names>K</given-names></name><name><surname>Munir</surname><given-names>MB</given-names></name><name><surname>Fatima</surname><given-names>A</given-names></name></person-group><article-title>Periodontal disease in type 2 diabetes mellitus</article-title><source>J Coll Physicians Surg Pak</source><year>2012</year><volume>22</volume><issue>8</issue><fpage>514</fpage><lpage>518</lpage><pub-id pub-id-type="pmid">22868018</pub-id></element-citation></ref><ref id="r16"><label>16</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Heitz-Mayfield</surname><given-names>LJ</given-names></name></person-group><article-title>Disease progression: identification of high-risk groups and
individuals for periodontitis</article-title><source>J Clin Periodontol</source><year>2005</year><volume>32</volume><issue>Suppl 6</issue><fpage>196</fpage><lpage>209</lpage><pub-id pub-id-type="pmid">16128838</pub-id></element-citation></ref><ref id="r17"><label>17</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Kardegler</surname><given-names>L</given-names></name><name><surname>Buduneli</surname><given-names>N</given-names></name><name><surname>Cetinkalp</surname><given-names>S</given-names></name><name><surname>Kinane</surname><given-names>DF</given-names></name></person-group><article-title>Adipokines and inflammatory mediators after initial periodontal
treatment in patients with type 2 diabetes and chronic
periodontitis</article-title><source>J Periodontol</source><year>2010</year><volume>81</volume><issue>1</issue><fpage>24</fpage><lpage>33</lpage><pub-id pub-id-type="pmid">20059414</pub-id></element-citation></ref><ref id="r18"><label>18</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Khosravi</surname><given-names>R</given-names></name><name><surname>Ka</surname><given-names>K</given-names></name><name><surname>Huang</surname><given-names>T</given-names></name><name><surname>Khalili</surname><given-names>S</given-names></name><name><surname>Nguyen</surname><given-names>BH</given-names></name><name><surname>Nicolau</surname><given-names>B</given-names></name><etal>et al</etal></person-group><article-title>Tumor necrosis factor- a and interleukin-6: potential interorgan
inflammatory mediators contributing to destructive periodontal disease in obesity
or metabolic syndrome</article-title><source>Mediators Inflamm</source><year>2013</year><volume>2013</volume><fpage>728987</fpage><lpage>728987</lpage><pub-id pub-id-type="pmid">24068858</pub-id></element-citation></ref><ref id="r19"><label>19</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Koromantzos</surname><given-names>PA</given-names></name><name><surname>Makrilakis</surname><given-names>K</given-names></name><name><surname>Dereka</surname><given-names>X</given-names></name><name><surname>Offenbacher</surname><given-names>S</given-names></name><name><surname>Katsilambros</surname><given-names>N</given-names></name><name><surname>Vrotsos</surname><given-names>IA</given-names></name><etal>et al</etal></person-group><article-title>Effect of non-surgical periodontal therapy on C-reactive protein,
oxidative stress, and matrix metalloproteinase (MMP)-9 and MMP-2 levels in
patients with type 2 diabetes: a randomized controlled study</article-title><source>J Periodontol</source><year>2012</year><volume>83</volume><issue>1</issue><fpage>3</fpage><lpage>10</lpage><pub-id pub-id-type="pmid">21627458</pub-id></element-citation></ref><ref id="r20"><label>20</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Lalla</surname><given-names>E</given-names></name><name><surname>Papapanou</surname><given-names>PN</given-names></name></person-group><article-title>Diabetes mellitus and periodontitis: a tale of two common interrelated
diseases</article-title><source>Nat Rev Endocrinol</source><year>2011</year><volume>7</volume><issue>12</issue><fpage>738</fpage><lpage>748</lpage><pub-id pub-id-type="pmid">21709707</pub-id></element-citation></ref><ref id="r21"><label>21</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Larsen</surname><given-names>CM</given-names></name><name><surname>Faulenbach</surname><given-names>M</given-names></name><name><surname>Vaag</surname><given-names>A</given-names></name><name><surname>Ehses</surname><given-names>JA</given-names></name><name><surname>Donath</surname><given-names>MY</given-names></name><name><surname>Mandrup-Poulsen</surname><given-names>T</given-names></name></person-group><article-title>Sustained effects of interleukin-1 receptor antagonist treatment in
type 2 diabetes</article-title><source>Diabetes Care</source><year>2009</year><volume>32</volume><issue>9</issue><fpage>1663</fpage><lpage>1668</lpage><pub-id pub-id-type="pmid">19542207</pub-id></element-citation></ref><ref id="r22"><label>22</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Litwak</surname><given-names>L</given-names></name><name><surname>Goh</surname><given-names>SY</given-names></name><name><surname>Hussein</surname><given-names>Z</given-names></name><name><surname>Malek</surname><given-names>R</given-names></name><name><surname>Prusty</surname><given-names>V</given-names></name><name><surname>Khamseh</surname><given-names>ME</given-names></name></person-group><article-title>Prevalence of diabetes complications in people with type 2 diabetes
mellitus and its association with baseline characteristics in the multinational
A1chieve study</article-title><source>Diabetol Metab Syndr</source><year>2013</year><volume>5</volume><issue>1</issue><fpage>57</fpage><lpage>57</lpage><pub-id pub-id-type="pmid">24228724</pub-id></element-citation></ref><ref id="r23"><label>23</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Mao</surname><given-names>XM</given-names></name><name><surname>Liu</surname><given-names>H</given-names></name><name><surname>Tao</surname><given-names>XJ</given-names></name><name><surname>Yin</surname><given-names>GP</given-names></name><name><surname>Li</surname><given-names>Q</given-names></name><name><surname>Wang</surname><given-names>SK</given-names></name></person-group><article-title>Independent antiinflammatory effect of insulin in newly diagnosed type
2 diabetes</article-title><source>Diabetes Metab Res Rev</source><year>2009</year><volume>25</volume><issue>5</issue><fpage>435</fpage><lpage>441</lpage><pub-id pub-id-type="pmid">19405039</pub-id></element-citation></ref><ref id="r24"><label>24</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Mealey</surname><given-names>B</given-names></name><name><surname>Oates</surname><given-names>T</given-names></name><collab>American Academy of Periodontology</collab></person-group><article-title>Diabetes mellitus and periodontal diseases</article-title><source>J Periodontol</source><year>2006</year><volume>77</volume><issue>8</issue><fpage>1289</fpage><lpage>1303</lpage><pub-id pub-id-type="pmid">16881798</pub-id></element-citation></ref><ref id="r25"><label>25</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Nibali</surname><given-names>L</given-names></name><name><surname>Fedele</surname><given-names>S</given-names></name><name><surname>D'Aiuto</surname><given-names>F</given-names></name><name><surname>Donos</surname><given-names>N</given-names></name></person-group><article-title>Interleukin-6 in oral diseases: a review</article-title><source>Oral Dis</source><year>2012</year><volume>18</volume><issue>3</issue><fpage>236</fpage><lpage>243</lpage><pub-id pub-id-type="pmid">22050374</pub-id></element-citation></ref><ref id="r26"><label>26</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Odegaard</surname><given-names>JI</given-names></name><name><surname>Ricardo-Gonzalez</surname><given-names>RR</given-names></name><name><surname>Goforth</surname><given-names>MH</given-names></name><name><surname>Morel</surname><given-names>CR</given-names></name><name><surname>Subramanian</surname><given-names>V</given-names></name><name><surname>Mukundan</surname><given-names>L</given-names></name><etal>et al</etal></person-group><article-title>Macrophage-specific PPARgamma controls alternative activation and
improves insulin resistance</article-title><source>Nature</source><year>2007</year><volume>447</volume><issue>7148</issue><fpage>1116</fpage><lpage>1120</lpage><pub-id pub-id-type="pmid">17515919</pub-id></element-citation></ref><ref id="r27"><label>27</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Sakallio&#x0011f;lu</surname><given-names>EE</given-names></name><name><surname>Ayas</surname><given-names>B</given-names></name><name><surname>L&#x000fc;tfio&#x0011f;lu</surname><given-names>M</given-names></name><name><surname>Kele&#x0015f;</surname><given-names>GC</given-names></name><name><surname>A&#x000e7;ikg&#x000f6;z</surname><given-names>G</given-names></name><name><surname>Firatli</surname><given-names>E</given-names></name></person-group><article-title>Gingival levels of monocyte chemoattractant protein-1 (MCP-1) in
diabetes mellitus and periodontitis: an experimental study in rats</article-title><source>Clin Oral Investig</source><year>2008</year><volume>12</volume><issue>1</issue><fpage>83</fpage><lpage>89</lpage></element-citation></ref><ref id="r28"><label>28</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Saremi</surname><given-names>A</given-names></name><name><surname>Nelson</surname><given-names>RG</given-names></name><name><surname>Tulloch-Reid</surname><given-names>M</given-names></name><name><surname>Hanson</surname><given-names>RL</given-names></name><name><surname>Sievers</surname><given-names>ML</given-names></name><name><surname>Taylor</surname><given-names>GW</given-names></name><etal>et al</etal></person-group><article-title>Periodontal disease and mortality in type 2 diabetes</article-title><source>Diabetes Care</source><year>2005</year><volume>28</volume><issue>1</issue><fpage>27</fpage><lpage>32</lpage><pub-id pub-id-type="pmid">15616229</pub-id></element-citation></ref><ref id="r29"><label>29</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Shoelson</surname><given-names>SE</given-names></name><name><surname>Lee</surname><given-names>J</given-names></name><name><surname>Goldfine</surname><given-names>AB</given-names></name></person-group><article-title>Inflammation and insulin resistance</article-title><source>J Clin Invest</source><year>2006</year><volume>116</volume><issue>7</issue><fpage>1793</fpage><lpage>1801</lpage><pub-id pub-id-type="pmid">16823477</pub-id></element-citation></ref><ref id="r30"><label>30</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Southerland</surname><given-names>JH</given-names></name><name><surname>Moss</surname><given-names>K</given-names></name><name><surname>Taylor</surname><given-names>GW</given-names></name><name><surname>Beck</surname><given-names>JD</given-names></name><name><surname>Pankow</surname><given-names>J</given-names></name><name><surname>Gangula</surname><given-names>PR</given-names></name><etal>et al</etal></person-group><article-title>Periodontitis and diabetes associations with measures of
atherosclerosis and CHD</article-title><source>Atherosclerosis</source><year>2012</year><volume>222</volume><issue>1</issue><fpage>196</fpage><lpage>201</lpage><pub-id pub-id-type="pmid">22440543</pub-id></element-citation></ref><ref id="r31"><label>31</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Southerland</surname><given-names>JH</given-names></name><name><surname>Taylor</surname><given-names>GW</given-names></name><name><surname>Moss</surname><given-names>K</given-names></name><name><surname>Beck</surname><given-names>JD</given-names></name><name><surname>Offenbacher</surname><given-names>S</given-names></name></person-group><article-title>Commonality in chronic inflammatory diseases: periodontitis, diabetes,
and coronary artery disease</article-title><source>Periodontol 2000</source><year>2006</year><volume>40</volume><fpage>130</fpage><lpage>143</lpage><pub-id pub-id-type="pmid">16398690</pub-id></element-citation></ref><ref id="r32"><label>32</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Sun</surname><given-names>WL</given-names></name><name><surname>Chen</surname><given-names>LL</given-names></name><name><surname>Zhang</surname><given-names>SZ</given-names></name><name><surname>Wu</surname><given-names>YM</given-names></name><name><surname>Ren</surname><given-names>YZ</given-names></name><name><surname>Qin</surname><given-names>GM</given-names></name></person-group><article-title>Inflammatory cytokines, adiponectin, insulin resistance and metabolic
control after periodontal intervention in patients with type 2 diabetes and
chronic periodontitis</article-title><source>Intern Med</source><year>2011</year><volume>50</volume><issue>15</issue><fpage>1569</fpage><lpage>1574</lpage><pub-id pub-id-type="pmid">21804283</pub-id></element-citation></ref><ref id="r33"><label>33</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Talbert</surname><given-names>J</given-names></name><name><surname>Elter</surname><given-names>J</given-names></name><name><surname>Jared</surname><given-names>HL</given-names></name><name><surname>Offenbacher</surname><given-names>S</given-names></name><name><surname>Southerland</surname><given-names>J</given-names></name><name><surname>Wilder</surname><given-names>RS</given-names></name></person-group><article-title>The effect of periodontal therapy on TNF-alpha, IL-6 and metabolic
control in type 2 diabetics</article-title><source>J Dent Hyg</source><year>2006</year><volume>80</volume><issue>2</issue><fpage>7</fpage><lpage>22</lpage><pub-id pub-id-type="pmid">16734992</pub-id></element-citation></ref><ref id="r34"><label>34</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Tanwir</surname><given-names>F</given-names></name><name><surname>Tariq</surname><given-names>A</given-names></name></person-group><article-title>Effect of glycemic control on periodontal status</article-title><source>J Coll Physicians Surg Pak</source><year>2012</year><volume>22</volume><issue>6</issue><fpage>371</fpage><lpage>374</lpage><pub-id pub-id-type="pmid">22630096</pub-id></element-citation></ref><ref id="r35"><label>35</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Venza</surname><given-names>I</given-names></name><name><surname>Visalli</surname><given-names>M</given-names></name><name><surname>Cucinotta</surname><given-names>M</given-names></name><name><surname>De Grazia</surname><given-names>G</given-names></name><name><surname>Teti</surname><given-names>D</given-names></name><name><surname>Venza</surname><given-names>M</given-names></name></person-group><article-title>Proinflammatory gene expression at chronic periodontitis and
peri-implantitis sites in patients with or without type 2 diabetes</article-title><source>J Periodontol</source><year>2010</year><volume>81</volume><issue>1</issue><fpage>99</fpage><lpage>108</lpage><pub-id pub-id-type="pmid">20059422</pub-id></element-citation></ref></ref-list></back></article>